Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Oropharynx Squamous Cell Carcinoma: early-phase trial registry
6 of 7 indexed Oropharynx Squamous Cell Carcinoma trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 6 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Oropharynx Squamous Cell Carcinoma: 7 US clinical trials tracked, 6 recruiting.
Oropharynx Squamous Cell Carcinoma is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 3 in Phase 1-2 (earlier-stage). The most active sponsor is Joseph Califano, running 1 of these trials.
Enrollment posture brief
Registry condition oropharynx-squamous-cell-carcinoma
OPEN 6 | RECR 86% | LATE 0 | EARLY 3 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Adenovirus (86% recruiting · 7 trials)
Oropharynx Squamous Cell Carcinoma lists 6 open slots (86% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Oropharynx Squamous Cell Carcinoma on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Oropharynx Squamous Cell Carcinoma is recruiting above its size-band peers.
6 of 7 indexed trials (85.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Oropharynx Squamous Cell Carcinoma trials is spread across many organizations.
Joseph Califano accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Most Oropharynx Squamous Cell Carcinoma trials plan to enrol fewer than 100 people.
Median target enrolment is 85 among the 7 trials that report a genuine target (sentinel values excluded). 5 of those (71.4%) plan for fewer than 100 participants.
-
Oropharynx Squamous Cell Carcinoma splits between interventional and observational designs.
4 interventional and 3 observational studies make up this index (57.1% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Viome
NCT05451303
Prospective Observational Study to Validate Circulating HPVDNA and Prognostic Genomic Biomarkers in HPV-associated OPSCC
UNC Lineberger Comprehensive Cancer Center
NCT04564989
Training Swallowing Initiation During Expiration
Northwestern University
NCT05278039
Selective Adjuvant Therapy for HPV-mediated Oropharynx SCCs Based on Residual Circulating Tumor DNA Levels (SAVAL)
University of Maryland, Baltimore
NCT06088381
A Study of Sacituzumab Govitecan in Combination With Cetuximab in People With Head and Neck Squamous Cell Cancer (HNSCC)
Memorial Sloan Kettering Cancer Center
NCT07063212
First Line Weekly Chemo/Immunotherapy for Metastatic Head/Neck Squamous Cell Carcinoma Patients
Wake Forest University Health Sciences
NCT04858269
Saliva-based Detection of CD44
Joseph Califano
NCT03148665
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 2 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Oropharynx Squamous Cell Carcinoma records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Oropharynx Squamous Cell Carcinoma trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Oropharynx Squamous Cell Carcinoma page
7 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Oropharynx Squamous Cell Carcinoma trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Joseph Califano sponsors the most Oropharynx Squamous Cell Carcinoma trials on record, review their full trial history before evaluating a specific study. See Joseph Califano's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Oropharynx Squamous Cell Carcinoma condition card totals 7 registered trials; most-linked intervention OncAlert; top US site state New York. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.